Valitas Health Services Signs Merger Agreement with America Service Group

Valitas Health Services, Inc., the parent company of Correctional Medical Services, Inc., and America Service Group Inc. (NASDAQ: ASGR), the parent company of PHS Correctional Healthcare, Inc., announced today the signing of an agreement and plan of merger (the Merger Agreement) under which the two companies would be combined, bringing together two leading companies in the correctional healthcare field -- America Service Group's PHS Correctional Healthcare (PHS) and Valitas' Correctional Medical Services (CMS). Upon completion of the transaction, the combined company will have approximately 11,000 employees and independent contractors and will serve more than 400 correctional facilities. The combined company's annual revenues are expected to total approximately $1.4 billion for 2011.

Read more: America Service Group Inc ( ASGR )

Medipattern Receives FDA Clearance For Visualize:Vascular(TM)

Commercial Rollout of 3D Vascular Ultrasound Imaging Product Expected in The First Half of 2011

The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical imaging software solutions that help medical practitioners to better understand lesions and critical anatomy, is pleased to announce it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Visualize:Vascular(TM) product. Visualize:Vascular is designed to quantify image data; segmenting and measuring regions of interest in vessels. Visualize can help a physician assess vascular disease using ultrasound imaging readily available in most cardiology, vascular radiology and vascular surgery practices today. The product is now available for sale in the United States. First shipments are anticipated in the second quarter of this calendar year.

Read more: The Medipattern Corporation ( MKI )

Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress

Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2010.

Total revenue increased to $46.3 million in the third quarter of 2010, compared with $39.5 million in the third quarter of 2009. Product revenue was $45.8 million in the third quarter of 2010, an increase of 18 percent, compared with $38.9 million in the third quarter of 2009.

Net income was $3.7 million in the third quarter of 2010, compared with a net loss of $502,000 in the third quarter of 2009. Basic and diluted net income per share was $0.13 and $0.12, respectively, in the third quarter of 2010, compared with basic and diluted net loss per share of $0.02 in the third quarter of 2009.

Read more: Genomic Health Inc ( GHDX )

athenahealth, Inc. Reports Third Quarter Fiscal Year 2010 Results 

-- 33% Revenue Growth Over Third Quarter of 2009
-- GAAP Net Income of $3.8 Million, or $0.11 Per Diluted Share
-- Non-GAAP Adjusted Net Income of $6.4 Million, or $0.18 Per Diluted Share

athenahealth, Inc. (Nasdaq:ATHN), (the “Company”), a leading provider of web-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced financial and operational results for the third quarter of fiscal year 2010. The Company will conduct a conference call on Friday, October 22, 2010, at 8:00 a.m. Eastern Time to discuss these results and management’s outlook for future financial and operational performance. In addition, the Company has furnished prepared remarks in conjunction with this press release via a Current Report on Form 8-K.

Read more: athenahealth Inc ( ATHN )